Global Marburgvirus Infection Market Research Report 2023

The global Marburgvirus Infection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Marburgvirus Infection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Marburgvirus Infection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Marburgvirus Infection in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Marburgvirus Infection include Arno Therapeutics Inc, BioCryst Pharmaceuticals Inc, Eisai Co Ltd, Emergent BioSolutions Inc, Fab'entech SA, Integrated BioTherapeutics Inc, Johnson & Johnson, NanoViricides Inc and Profectus BioSciences Inc, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Marburgvirus Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Marburgvirus Infection.

The Marburgvirus Infection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Marburgvirus Infection market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Marburgvirus Infection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Marburgvirus Infection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Eritoran Tetrasodium

1.2.3 AR-12

1.2.4 ARD-5

1.2.5 AVI-7288

1.2.6 Others

1.3 Market by Application

1.3.1 Global Marburgvirus Infection Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Marburgvirus Infection Market Perspective (2018-2029)

2.2 Marburgvirus Infection Growth Trends by Region

2.2.1 Global Marburgvirus Infection Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Marburgvirus Infection Historic Market Size by Region (2018-2023)

2.2.3 Marburgvirus Infection Forecasted Market Size by Region (2024-2029)

2.3 Marburgvirus Infection Market Dynamics

2.3.1 Marburgvirus Infection Industry Trends

2.3.2 Marburgvirus Infection Market Drivers

2.3.3 Marburgvirus Infection Market Challenges

2.3.4 Marburgvirus Infection Market Restraints

3.1 Global Top Marburgvirus Infection Players by Revenue

3.1.1 Global Top Marburgvirus Infection Players by Revenue (2018-2023)

3.1.2 Global Marburgvirus Infection Revenue Market Share by Players (2018-2023)

3.2 Global Marburgvirus Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Marburgvirus Infection Revenue

3.4 Global Marburgvirus Infection Market Concentration Ratio

3.4.1 Global Marburgvirus Infection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Marburgvirus Infection Revenue in 2022

3.5 Marburgvirus Infection Key Players Head office and Area Served

3.6 Key Players Marburgvirus Infection Product Solution and Service

3.7 Date of Enter into Marburgvirus Infection Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Marburgvirus Infection Historic Market Size by Type (2018-2023)

4.2 Global Marburgvirus Infection Forecasted Market Size by Type (2024-2029)

5.1 Global Marburgvirus Infection Historic Market Size by Application (2018-2023)

5.2 Global Marburgvirus Infection Forecasted Market Size by Application (2024-2029)

6.1 North America Marburgvirus Infection Market Size (2018-2029)

6.2 North America Marburgvirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Marburgvirus Infection Market Size by Country (2018-2023)

6.4 North America Marburgvirus Infection Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Marburgvirus Infection Market Size (2018-2029)

7.2 Europe Marburgvirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Marburgvirus Infection Market Size by Country (2018-2023)

7.4 Europe Marburgvirus Infection Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Marburgvirus Infection Market Size (2018-2029)

8.2 Asia-Pacific Marburgvirus Infection Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Marburgvirus Infection Market Size by Region (2018-2023)

8.4 Asia-Pacific Marburgvirus Infection Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Marburgvirus Infection Market Size (2018-2029)

9.2 Latin America Marburgvirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Marburgvirus Infection Market Size by Country (2018-2023)

9.4 Latin America Marburgvirus Infection Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Marburgvirus Infection Market Size (2018-2029)

10.2 Middle East & Africa Marburgvirus Infection Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Marburgvirus Infection Market Size by Country (2018-2023)

10.4 Middle East & Africa Marburgvirus Infection Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Arno Therapeutics Inc

11.1.1 Arno Therapeutics Inc Company Detail

11.1.2 Arno Therapeutics Inc Business Overview

11.1.3 Arno Therapeutics Inc Marburgvirus Infection Introduction

11.1.4 Arno Therapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023)

11.1.5 Arno Therapeutics Inc Recent Development

11.2 BioCryst Pharmaceuticals Inc

11.2.1 BioCryst Pharmaceuticals Inc Company Detail

11.2.2 BioCryst Pharmaceuticals Inc Business Overview

11.2.3 BioCryst Pharmaceuticals Inc Marburgvirus Infection Introduction

11.2.4 BioCryst Pharmaceuticals Inc Revenue in Marburgvirus Infection Business (2018-2023)

11.2.5 BioCryst Pharmaceuticals Inc Recent Development

11.3 Eisai Co Ltd

11.3.1 Eisai Co Ltd Company Detail

11.3.2 Eisai Co Ltd Business Overview

11.3.3 Eisai Co Ltd Marburgvirus Infection Introduction

11.3.4 Eisai Co Ltd Revenue in Marburgvirus Infection Business (2018-2023)

11.3.5 Eisai Co Ltd Recent Development

11.4 Emergent BioSolutions Inc

11.4.1 Emergent BioSolutions Inc Company Detail

11.4.2 Emergent BioSolutions Inc Business Overview

11.4.3 Emergent BioSolutions Inc Marburgvirus Infection Introduction

11.4.4 Emergent BioSolutions Inc Revenue in Marburgvirus Infection Business (2018-2023)

11.4.5 Emergent BioSolutions Inc Recent Development

11.5 Fab'entech SA

11.5.1 Fab'entech SA Company Detail

11.5.2 Fab'entech SA Business Overview

11.5.3 Fab'entech SA Marburgvirus Infection Introduction

11.5.4 Fab'entech SA Revenue in Marburgvirus Infection Business (2018-2023)

11.5.5 Fab'entech SA Recent Development

11.6 Integrated BioTherapeutics Inc

11.6.1 Integrated BioTherapeutics Inc Company Detail

11.6.2 Integrated BioTherapeutics Inc Business Overview

11.6.3 Integrated BioTherapeutics Inc Marburgvirus Infection Introduction

11.6.4 Integrated BioTherapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023)

11.6.5 Integrated BioTherapeutics Inc Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Detail

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Marburgvirus Infection Introduction

11.7.4 Johnson & Johnson Revenue in Marburgvirus Infection Business (2018-2023)

11.7.5 Johnson & Johnson Recent Development

11.8 NanoViricides Inc

11.8.1 NanoViricides Inc Company Detail

11.8.2 NanoViricides Inc Business Overview

11.8.3 NanoViricides Inc Marburgvirus Infection Introduction

11.8.4 NanoViricides Inc Revenue in Marburgvirus Infection Business (2018-2023)

11.8.5 NanoViricides Inc Recent Development

11.9 Profectus BioSciences Inc

11.9.1 Profectus BioSciences Inc Company Detail

11.9.2 Profectus BioSciences Inc Business Overview

11.9.3 Profectus BioSciences Inc Marburgvirus Infection Introduction

11.9.4 Profectus BioSciences Inc Revenue in Marburgvirus Infection Business (2018-2023)

11.9.5 Profectus BioSciences Inc Recent Development

11.10 Rodos BioTarget GmbH

11.10.1 Rodos BioTarget GmbH Company Detail

11.10.2 Rodos BioTarget GmbH Business Overview

11.10.3 Rodos BioTarget GmbH Marburgvirus Infection Introduction

11.10.4 Rodos BioTarget GmbH Revenue in Marburgvirus Infection Business (2018-2023)

11.10.5 Rodos BioTarget GmbH Recent Development

11.11 Sarepta Therapeutics Inc

11.11.1 Sarepta Therapeutics Inc Company Detail

11.11.2 Sarepta Therapeutics Inc Business Overview

11.11.3 Sarepta Therapeutics Inc Marburgvirus Infection Introduction

11.11.4 Sarepta Therapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023)

11.11.5 Sarepta Therapeutics Inc Recent Development

11.12 Theravectys SA

11.12.1 Theravectys SA Company Detail

11.12.2 Theravectys SA Business Overview

11.12.3 Theravectys SA Marburgvirus Infection Introduction

11.12.4 Theravectys SA Revenue in Marburgvirus Infection Business (2018-2023)

11.12.5 Theravectys SA Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Marburgvirus Infection Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Eritoran Tetrasodium

    Table 3. Key Players of AR-12

    Table 4. Key Players of ARD-5

    Table 5. Key Players of AVI-7288

    Table 6. Key Players of Others

    Table 7. Global Marburgvirus Infection Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Marburgvirus Infection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Marburgvirus Infection Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Marburgvirus Infection Market Share by Region (2018-2023)

    Table 11. Global Marburgvirus Infection Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Marburgvirus Infection Market Share by Region (2024-2029)

    Table 13. Marburgvirus Infection Market Trends

    Table 14. Marburgvirus Infection Market Drivers

    Table 15. Marburgvirus Infection Market Challenges

    Table 16. Marburgvirus Infection Market Restraints

    Table 17. Global Marburgvirus Infection Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Marburgvirus Infection Market Share by Players (2018-2023)

    Table 19. Global Top Marburgvirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marburgvirus Infection as of 2022)

    Table 20. Ranking of Global Top Marburgvirus Infection Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Marburgvirus Infection Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Marburgvirus Infection Product Solution and Service

    Table 24. Date of Enter into Marburgvirus Infection Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Marburgvirus Infection Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Marburgvirus Infection Revenue Market Share by Type (2018-2023)

    Table 28. Global Marburgvirus Infection Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Marburgvirus Infection Revenue Market Share by Type (2024-2029)

    Table 30. Global Marburgvirus Infection Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Marburgvirus Infection Revenue Market Share by Application (2018-2023)

    Table 32. Global Marburgvirus Infection Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Marburgvirus Infection Revenue Market Share by Application (2024-2029)

    Table 34. North America Marburgvirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Marburgvirus Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Marburgvirus Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Marburgvirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Marburgvirus Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Marburgvirus Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Marburgvirus Infection Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Marburgvirus Infection Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Marburgvirus Infection Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Marburgvirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Marburgvirus Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Marburgvirus Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Marburgvirus Infection Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Marburgvirus Infection Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Marburgvirus Infection Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Arno Therapeutics Inc Company Detail

    Table 50. Arno Therapeutics Inc Business Overview

    Table 51. Arno Therapeutics Inc Marburgvirus Infection Product

    Table 52. Arno Therapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 53. Arno Therapeutics Inc Recent Development

    Table 54. BioCryst Pharmaceuticals Inc Company Detail

    Table 55. BioCryst Pharmaceuticals Inc Business Overview

    Table 56. BioCryst Pharmaceuticals Inc Marburgvirus Infection Product

    Table 57. BioCryst Pharmaceuticals Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 58. BioCryst Pharmaceuticals Inc Recent Development

    Table 59. Eisai Co Ltd Company Detail

    Table 60. Eisai Co Ltd Business Overview

    Table 61. Eisai Co Ltd Marburgvirus Infection Product

    Table 62. Eisai Co Ltd Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 63. Eisai Co Ltd Recent Development

    Table 64. Emergent BioSolutions Inc Company Detail

    Table 65. Emergent BioSolutions Inc Business Overview

    Table 66. Emergent BioSolutions Inc Marburgvirus Infection Product

    Table 67. Emergent BioSolutions Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 68. Emergent BioSolutions Inc Recent Development

    Table 69. Fab'entech SA Company Detail

    Table 70. Fab'entech SA Business Overview

    Table 71. Fab'entech SA Marburgvirus Infection Product

    Table 72. Fab'entech SA Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 73. Fab'entech SA Recent Development

    Table 74. Integrated BioTherapeutics Inc Company Detail

    Table 75. Integrated BioTherapeutics Inc Business Overview

    Table 76. Integrated BioTherapeutics Inc Marburgvirus Infection Product

    Table 77. Integrated BioTherapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 78. Integrated BioTherapeutics Inc Recent Development

    Table 79. Johnson & Johnson Company Detail

    Table 80. Johnson & Johnson Business Overview

    Table 81. Johnson & Johnson Marburgvirus Infection Product

    Table 82. Johnson & Johnson Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 83. Johnson & Johnson Recent Development

    Table 84. NanoViricides Inc Company Detail

    Table 85. NanoViricides Inc Business Overview

    Table 86. NanoViricides Inc Marburgvirus Infection Product

    Table 87. NanoViricides Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 88. NanoViricides Inc Recent Development

    Table 89. Profectus BioSciences Inc Company Detail

    Table 90. Profectus BioSciences Inc Business Overview

    Table 91. Profectus BioSciences Inc Marburgvirus Infection Product

    Table 92. Profectus BioSciences Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 93. Profectus BioSciences Inc Recent Development

    Table 94. Rodos BioTarget GmbH Company Detail

    Table 95. Rodos BioTarget GmbH Business Overview

    Table 96. Rodos BioTarget GmbH Marburgvirus Infection Product

    Table 97. Rodos BioTarget GmbH Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 98. Rodos BioTarget GmbH Recent Development

    Table 99. Sarepta Therapeutics Inc Company Detail

    Table 100. Sarepta Therapeutics Inc Business Overview

    Table 101. Sarepta Therapeutics Inc Marburgvirus Infection Product

    Table 102. Sarepta Therapeutics Inc Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 103. Sarepta Therapeutics Inc Recent Development

    Table 104. Theravectys SA Company Detail

    Table 105. Theravectys SA Business Overview

    Table 106. Theravectys SA Marburgvirus Infection Product

    Table 107. Theravectys SA Revenue in Marburgvirus Infection Business (2018-2023) & (US$ Million)

    Table 108. Theravectys SA Recent Development

    Table 109. Research Programs/Design for This Report

    Table 110. Key Data Information from Secondary Sources

    Table 111. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Marburgvirus Infection Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Marburgvirus Infection Market Share by Type: 2022 VS 2029

    Figure 3. Eritoran Tetrasodium Features

    Figure 4. AR-12 Features

    Figure 5. ARD-5 Features

    Figure 6. AVI-7288 Features

    Figure 7. Others Features

    Figure 8. Global Marburgvirus Infection Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Marburgvirus Infection Market Share by Application: 2022 VS 2029

    Figure 10. Hospital Case Studies

    Figure 11. Clinic Case Studies

    Figure 12. Others Case Studies

    Figure 13. Marburgvirus Infection Report Years Considered

    Figure 14. Global Marburgvirus Infection Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Marburgvirus Infection Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Marburgvirus Infection Market Share by Region: 2022 VS 2029

    Figure 17. Global Marburgvirus Infection Market Share by Players in 2022

    Figure 18. Global Top Marburgvirus Infection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Marburgvirus Infection as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Marburgvirus Infection Revenue in 2022

    Figure 20. North America Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Marburgvirus Infection Market Share by Country (2018-2029)

    Figure 22. United States Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Marburgvirus Infection Market Share by Country (2018-2029)

    Figure 26. Germany Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Marburgvirus Infection Market Share by Region (2018-2029)

    Figure 34. China Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Marburgvirus Infection Market Share by Country (2018-2029)

    Figure 42. Mexico Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Marburgvirus Infection Market Share by Country (2018-2029)

    Figure 46. Turkey Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Marburgvirus Infection Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Arno Therapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 49. BioCryst Pharmaceuticals Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 50. Eisai Co Ltd Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 51. Emergent BioSolutions Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 52. Fab'entech SA Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 53. Integrated BioTherapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 54. Johnson & Johnson Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 55. NanoViricides Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 56. Profectus BioSciences Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 57. Rodos BioTarget GmbH Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 58. Sarepta Therapeutics Inc Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 59. Theravectys SA Revenue Growth Rate in Marburgvirus Infection Business (2018-2023)

    Figure 60. Bottom-up and Top-down Approaches for This Report

    Figure 61. Data Triangulation

    Figure 62. Key Executives Interviewed